Insiders Viracta Therapeutics, Inc.

Equities

VIRX

US92765F1084

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-30 pm EDT			5-day change	1st Jan Change
0.8196 ^USD	-0.17%		-3.33%	+43.79%

Apr. 15	Viracta Therapeutics, Inc. Reports Positive Topline Results from Stage 1 of the Pivotal Phase 2 NAVAL-1 Trial	CI
Apr. 01	Viracta Therapeutics to Present Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial at the 2024 Annual Congress of The Hematology Society of Taiwan	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Viracta Therapeutics, Inc. Announces Executive Changes	Mar. 20	CI
Viracta Therapeutics, Inc. Appoints Darrel P. Cohen, M.D., Ph.D. as Chief Medical Officer	23-08-08	CI
Viracta Therapeutics, Inc. Announces Departure of Lisa Rojkjaer as Chief Medical Officer	23-05-02	CI
Viracta Therapeutics, Inc. Announces Nicole Onetto Will Not Stand for Re-Election as Director	23-03-31	CI
Viracta Therapeutics Names Mark Rothera CEO	22-09-19	MT
Viracta Therapeutics, Inc. Announces Board and Executive Changes, Effective September 19, 2022	22-09-19	CI
Viracta Therapeutics, Inc. Announces CEO Changes	22-09-19	CI
Viracta Therapeutics, Inc. Announces Resignation of Michael Huang as Director	22-08-26	CI
Viracta Therapeutics Appoints Jane Chung, R.Ph., to its Board of Directors	22-08-11	CI
SQZ Biotechnologies Names Marshelle Warren as Chief Medical Officer	22-05-31	MT
Viracta Therapeutics, Inc. Announces That Gur Roshwalb Will Not Stand for Re-Election At the Company’s 2022 Annual Meeting of Stockholders	22-04-15	CI
Insider Sell: Viracta Therapeutics	21-11-30	MT
Viracta Therapeutics, Inc. Announces Board Appointments	21-08-16	CI
Viracta Therapeutics, Inc. Announces Executive Changes	21-03-04	CI
Viracta Therapeutics, Inc. Announces Executive Changes	21-02-24	CI
Viracta Therapeutics, Inc. Announces Board Changes	20-09-14	CI
Viracta Therapeutics, Inc. Announces Appointment of Roger J. Pomerantz, MD to its Board of Directors	20-07-14	CI
Viracta Therapeutics, Inc. Appoints Lisa Rojkjaer as Chief Medical Officer	20-03-25	CI
Viracta Therapeutics, Inc. Announces Management Changes	19-08-01	CI
Viracta Therapeutics, Inc. Announces Scientific Advisory Board Appointments	18-09-25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Viracta Therapeutics, Inc.

Equities

VIRX

US92765F1084

Insiders

Filters